scholarly journals PTH-099 Distinctive Gene Expression Profiles in the Whole Blood of Patients with Moderate to Severe Ulcerative Colitis and Crohn’S Disease

Gut ◽  
2013 ◽  
Vol 62 (Suppl 1) ◽  
pp. A251.2-A251
Author(s):  
S Telesco ◽  
K Li ◽  
C Marano ◽  
C Gasink ◽  
K Ma ◽  
...  
Genes ◽  
2021 ◽  
Vol 12 (10) ◽  
pp. 1477
Author(s):  
Daša Jevšinek Skok ◽  
Nina Hauptman ◽  
Miha Jerala ◽  
Nina Zidar

Ulcerative colitis (UC) and Crohn’s disease (CD) are characterized by an imbalance between pro-inflammatory and anti-inflammatory cytokines, interfering with the resolution of inflammation. Due to the crucial role of cytokines, new insights into their profiles in UC and CD would help to improve our understanding of pathogenesis and enable the development of new treatment modalities. We provide an expression profile of cytokines in UC and CD, using bioinformatics approach, and experimental validation of expression of the selected genes. We retrieved data and analyzed the cytokine gene expression profiles of UC and CD. From ten genes with inverse expression, common to CD and UC, BMP8B, LEFTY1 and INSL5 were selected for gene expression experimental validation. Experimentally, BMP8B and INSL5 were down-regulated in both CD and UC but followed the bioinformatics trend. The expression of genes LEFTY1 and BMP8B was statistically significant when comparing UC and CD in colon and the expression of gene LEFTY1 showed statistical significance when CD in ileum and colon were compared. Using the bioinformatics approach and experimental validation, we found differences in expression profiles between UC and CD for INSL5, LEFTY1 and BMP8B. These three promising candidate genes need to be further explored at different levels, such as DNA methylation and protein expression, to provide more evidence on their potential diagnostic role in CD and UC.


2018 ◽  
Vol 2018 ◽  
pp. 1-10 ◽  
Author(s):  
Maria Dobre ◽  
Elena Milanesi ◽  
Teodora Ecaterina Mănuc ◽  
Dorel Eugen Arsene ◽  
Cristian George Ţieranu ◽  
...  

Genetic research has shaped the inflammatory bowel disease (IBD) landscape identifying nearly two hundred risk loci. Nonetheless, the identified variants rendered only a partial success in providing criteria for the differential diagnosis between ulcerative colitis (UC) and Crohn’s disease (CD). Transcript levels from affected intestinal mucosa may serve as tentative biomarkers for improving classification and diagnosis of IBD. The aim of our study was to identify gene expression profiles specific for UC and CD, in endoscopically affected and normal intestinal colonic mucosa from IBD patients. We evaluated a panel of 84 genes related to the IBD-inflammatory pathway on 21 UC and 22 CD paired inflamed and not inflamed mucosa and on age-matched normal mucosa from 21 non-IBD controls. Two genes in UC (CCL11 and MMP10) and two in CD (C4BPB and IL1RN) showed an upregulation trend in both noninflamed and inflamed mucosa compared to controls. Our results suggest that the transcript levels of CCL11, MMP10, C4BPB, and IL1RN are candidate biomarkers that could help in clinical practice for the differential diagnosis between UC and CD and could guide new research on future therapeutic targets.


2012 ◽  
Vol 142 (5) ◽  
pp. S-879
Author(s):  
Ingrid Arijs ◽  
Jan Van der Goten ◽  
Marc Ferrante ◽  
Kathleen Machiels ◽  
Vicky De Preter ◽  
...  

2009 ◽  
Vol 136 (5) ◽  
pp. A-172
Author(s):  
Boyko Kabakchiev ◽  
Dan Turner ◽  
Jeffrey S. Hyams ◽  
David R. Mack ◽  
Neal S. LeLeiko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document